The aim of AllCaN Oesophageal is to create a world-class network dedicated to improving outcomes for oesophageal cancer patients. PPI is essential for research to make patient-centered improvements to healthcare & advance education. To accomplish this in AllCaN Oesophageal, a PPI panel will represent the patient experience, will provide feedback on outreach activities and will help to evaluate the short- and long-term impact of the work delivered through the AllCaN Oesophageal programme. In conjunction with the PPI panel, AllCaN Oesophageal will ensure that patient voices have equal weight at all governance levels. The AllCaN Oesophageal team are deeply committed to working with those with lived experiences. Our extensive PPI panel importantly reflects those with lived experience of either Barrett’s oesophagus or oesophageal cancer. John Clarke was diagnosed with Barrett's oesophagus at age 33 and is a PPI representative for AllCaN: ‘I am unlucky to have Barrett’s oesophagus, but I am lucky to know I have it. Awareness is the key with any condition. The sooner found the better.’
